Omkar Pharmachem Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported revenue was INR 1.35 million compared to INR 1.35 million a year ago. Net income was INR 0.837 million compared to INR 0.812 million a year ago. Basic earnings per share from continuing operations was INR 0.083 compared to INR 0.0805 a year ago.
For the nine months, revenue was INR 4.05 million compared to INR 4.05 million a year ago. Net income was INR 2.06 million compared to INR 1.82 million a year ago. Basic earnings per share from continuing operations was INR 0.2045 compared to INR 0.1807 a year ago.